Executive Profile

Robert J. Towarnicki Chief Executive Officer, President and Director, Nucleonics, Inc.

Age	Total Calculated Compensation	This person is connected to 2 Board Members in 2 different organizations across 3 different industries. See Board Relationships
60	--

Background

Mr. Robert J. Towarnicki serves as Chief Executive Officer and President of Makefield Therapeutics Inc. Mr.Towarnicki has over 30 years experience in the pharmaceutical and biotechnology industry. He served as President of three biotech companies and has raised over $200 Million USD for those companies to further the development of novel technologies including small molecule pharmaceuticals, PMA and 510k medical devices and diagnostic assays. He has extensive experience ... in product development, process scale-up and validation, production operations and marketing and sales. Importantly, Mr. Towarnicki has demonstrated an ability to identify and attract high quality personnel to establish a capable, efficient and focused organization enabling him to successfully raise venture capital and partnering revenues. He has been the Chief Executive Officer and President of Nucleonics, Inc., since joining in 2003. Mr. Towarnicki served as the Chief Executive Officer of Cell Pathways, Inc. (CPI) since October 1996 and its President since January 1998. From 1992 to 1996, he served as Chief Operating Officer and President at Integra Life Sciences Corporation, including Collatech, Inc., ABS Life Sciences Inc., Telios Pharmaceuticals, Inc. and Vitaphore Corporation. Mr. Towarnicki has wealth of experience in the development of new biological products in a variety of therapeutic areas, most notably his experience in developing Engerix-B, GlaxoSmithKline's hepatitis B vaccine. Mr. Towarnicki was the Founder of MediRel, Inc. and served as it's President and Chief Executive Officer from 1991 to 1992. He served as General Manager of Focus/MRL, Inc. (Focus Technologies) from 1989 to 1991. He served as Vice President of Development and Operations at Collagen Corporation from 1985 to 1989 and held a variety of operations management positions at Pfizer Pharmaceuticals and Merck & Co., Inc. from 1974 to 1985. Mr. Towarnicki served as the Chairman at Cell Pathways, Inc., since May 31, 2000. He has been Director of Nucleonics, Inc., since 2003. He serves as a Director of ExSAR Corporation. He served as a Director at The Pennsylvania Biotechnology Association. He served as Director of Cell Pathways, Inc. since October 1996. He served as Director of Integra Life Sciences Corporation. Mr. Towarnicki was a Ph.D. candidate in Pharmaceutical Chemistry at Temple University School of Pharmacy and received his M.S. and B.S. Degrees from Villanova University.

Corporate Headquarters 13 Summit Square Center Langhorne, Pennsylvania 19047-1098 United States Phone: 267-518-0100 Fax: 267-518-0054 Board Members Memberships Chief Executive Officer, President and Director Nucleonics, Inc. Director The Pennsylvania Biotechnology Association Director ExSAR Corporation 1996-N/A Former Chairman of the Board, Chief Executive Officer and President Cell Pathways, Inc. Education MS Villanova University BS 1973 Villanova University Other Affiliations Cell Pathways, Inc. Villanova University The Pennsylvania Biotechnology Association ExSAR Corporation Makefield Therapeutics Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.